Back to CJC-1295
CJC-1295 Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for CJC-1295.
Dosing & Reconstitution Guide
In human research settings, CJC-1295 with DAC has been administered at 1–2 mg per week. These doses were used in tightly controlled environments. It is not approved for general use.
Standard / Gradual Approach
2mg VialstandardPhaseDoseVolume
Week 1500mcg75 units
Week 2500mcg75 units
Week 31000mcg150 units
Week 41000mcg150 units
Protocol Summary
Subcutaneous (SQ): 2-3 times daily (typically before meals or at bedtime) · Dose range 50–150 mcg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
CJC-1295 DAC: 500 mcg 1–2x per week. CJC-1295 no DAC: 50-150 mcg before bed or post-workout for 5 days on 2 days off. Recommended cycle: 8–12 weeks with equal time off.
🧪 Quick Start
Vial Size
2 mg
BAC Water
3 mL
Concentration
700 mcg/unit
🧮 Dose Calculator
Concentration
6.7
mcg/unit
Draw Volume
75
units (0.750 mL)
For a 500 mcg dose, draw 75 units on a U-100 insulin syringe